Calnexin as a dual-role biomarker: antibody-based diagnosis and therapeutic targeting in lung cancer

In conclusion, this study establishes calnexin as a promising target for antibody-based lung cancer diagnosis and therapy, unlocking novel avenues for early detection and treatment.PMID:38303563

Source: BMB Reports - February 2, 2024 Category: Biochemistry Authors: Soyeon Lim Youngeun Ha Boram Lee Junho Shin Taiyoun Rhim Source Type: research